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destructive mechanisms, known as the secondary lesion. The
leading mechanisms of damage after SCI are excitoxicity, free
radicals’ overproduction, inflammation and apoptosis. On the
other hand, metallothionein (MT) is a low-molecular-weight
cystein-rich protein able to scavenge free radicals, such as
hydroxyl radicals. MT participation as a neuroprotective
mechanism after SCI is not known. The aim of the present
study is to describe the changes of MT protein content in the
acute phase after SCI in rats. Female Wistar rats weighing 200–
250 g were submitted to spinal cord contusion model, by means
of a computer-controlled device (NYU impactor). Rats
receiving laminectomy were used as a control group. Animals
were killed 2, 4, 8 and 24 h after surgery. MT was quantified by
the silver-saturation method, using atomic absorption spectro-
photometry. Preliminary results indicate an increased MT
content by effect of SCI of 20%, 13%, 83% and 105% at 2, 4,
8, and 24 h, respectively, as compared to sham group values.
These results suggest an induction of MT synthesis by SCI and
the possible participation of MT as a protective mechanism in
response to lesion.
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Diabetes is associated with an increased risk of cognitive
dysfunction mainly in older adults, which can be prevented by
maintaining good control of glycaemia. Caffeine is the most
widely consumed psycho-active substance, is suggested to
improve performance in learning and memory tasks, and may
also reduce the risk of diabetes possibly by increasing energy
expenditure and weight loss. Caffeine mostly acts as an
adenosine A2A receptor antagonist when consumed chroni-
cally and interestingly the density of this receptor increases
upon chronic brain insults such as hyperglycaemia. We now
treated a mouse model for type 2 diabetes associated with
obesity (NONcNZO10/Ltj from Jax Laboratories) with 1 g/L
caffeine in drinking water for 4 months, starting on the 7th
month of age. Caffeine reduced body weight and glycaemia of
diabetic mice. Histological analysis of brain sections revealed
the absence of cellular damage in the diabetic hippocampus
evaluated by Cresyl Violet staining of Nissl bodies and
FluoroJade-C staining of degenerating cells. Western blot
analysis showed that diabetes increased GFAP immunoreac-
tivity in the hippocampus and immunohistochemical analysis
indicated an increase in the number of GFAP positive cells in
the diabetic hippocampus, which was prevented by caffeine
treatment. This astrogliosis may reflect the need of the
hippocampus to maintain proper control of glucose home-
ostasis. The density of the synaptic proteins SNAP25 and
synaptophysin was decreased in the diabetic hippocampus,
suggesting an impairment of synaptic connectivity. These
synaptic modifications were partially prevented by caffeine
treatment. The present results suggest that caffeine consump-
tion may help preventing diabetes-induced hippocampal
alterations that can lead to cognitive decline on aging.
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Huntington’s disease (HD) is a neurodegenerative disease
originated by increased glutamine repeats in the huntingtin-
protein (mhtt). An excitotoxic mechanism has associated with
the degeneration of the medium spiny neurons (MSN) in the
caudate-putamen. The R6/2 transgenic mice, which express the
N-terminal site of mhtt, show increased NMDA-induced
current activation. In addition, altered glutamate uptake
system has been described in R6/2 mice. These evidences
suggest that mhtt conduces to altered glutamatergic neuro-
transmission, possibly facilitating excitotoxicity. To test this
hypothesis we evaluated the vulnerability of R6/2 mice to the
intraestriatal administration of glutamate. Twenty four hours
after glutamate administration, larger lesions were observed in
the striatum of R6/2 as compared to wild type mice. On the
other hand, it is known that glutamate toxicity is exacerbated
during metabolic inhibition, and altered glycolysis has been
suggested from direct association between mhtt and the
glyrceraldehyde-3-phosphate dehydrogenase (GAPDH).
Therefore, we have tested glutamate toxicity in mice previously
treated with the GAPDH inhibitor iodoacetate (IOA). We
observed that GAPDH activity is more sensitive to IOA
treatment in transgenic than wild type mice. IOA treatment
increased glutamate toxicity both in wild type and transgenic
mice.
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Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is
the most frequent disorder of fatty acid oxidation. Biochemi-
cally, MCAD-deficient patients present tissue accumulation of
the medium-chain fatty acids octanoic, decanoic and cis-4-
decenoic (cDA) acids. Clinical presentation of MCAD
deficiency is related to fasting and increased metabolic stress,
which precipitate acute symptoms such as drowsiness or
lethargy that may develop into coma or even death. In the
present work, we investigated the in vitro effect of cDA on
respiratory parameters in mitochondrial preparations from rat
brain, namely states III and IV, as well as the respiratory
control ratio (RCR), using glutamate/malate and succinate as
r 2007 The Authors  Journal Compilation r 2007 International Society for Neurochemistry, J. Neurochem., 102 (Suppl. 1), 165–235 215
Molecular mechanisms involved in neuropathologies
